Asklepios BioPharmaceutical (AskBio)
Clinical-stage AAV gene therapy company for patients with rare diseases and other disorders
A gene therapy company changing lives with every genetic advancement.
At Asklepios BioPharmaceutical (AskBio), we are making history with every clinical advancement and aspire to turn hope into cures by unraveling new possibilities for genetic medicine. We became a wholly owned, independently operated subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy Platform.
AskBio is headquartered in Research Triangle Park, North Carolina, a thriving biotechnology hub with nearly 600 life science companies, and has additional research and development facilities in Edinburgh, Scotland, and Paris, France, and gene therapy manufacturing in San Sebastian, Spain.
Visit website: https://www.askbio.com/
Details last updated 31-Jul-2021
Asklepios BioPharmaceutical (AskBio) is also referenced in the following:
Synpromics
Company that develops and commercializes synthetic promoters to control gene expressions and regulations